Anavex Life Sciences Corp Share Price OTC Bulletin Board
Equities
AVXL
US0327971026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34Cr 2.82TCr |
---|---|---|---|---|---|
Net income 2024 * | -4.3Cr -358.97Cr | Net income 2025 * | -5.6Cr -467.5Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.67
x | P/E ratio 2025 * |
-6.23
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.95% |
Latest transcript on Anavex Life Sciences Corp
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 01/15/01 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Tom Skarpelos
FOU | Founder | 57 | 23/04/23 |
Jiong Ma
CHM | Chairman | 60 | 25/21/25 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-2.88% | 2.19TCr | |
-12.15% | 2.23TCr | |
-5.20% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr |
- Stock Market
- Equities
- AVXL Stock
- AVXL Stock